MicroCoat
Laboratory Services

Technologies & Platforms

Explore Microcoat's portfolio of analytical technologies, from ultrasensitive immunoassays and multiplex biomarker analysis to automated laboratory analyzers. Our team helps identify suitable platforms based on your analytes, sample matrices and analytical requirements.

Technologies
Technologies & Platforms
Our approach

The Right Platform Makes the Difference.

Selecting the right analytical technology early in a development project can help reduce unnecessary assay adaptation, make efficient use of limited sample material and support reliable data generation.

Microcoat combines experience across immunoassay formats, molecular methods and automated analytical systems to identify technologies that match the requirements of each project.

Benefits

Fit-for-Purpose

Technology selection based on the analyte, sample matrix and required assay performance.

Broad Expertise

Access to ultrasensitive immunoassays, multiplex protein analysis, automated clinical chemistry and molecular methods.

Efficient Development

Low-volume and multiplex technologies can reduce sample consumption and additional preparation steps.

Our technologies

Explore Our Technology Portfolio.

Simoa HD-X
Immunoassay Platforms

Simoa HD-X

Digital immunoassay technology for quantifying proteins at very low concentrations, including neurological biomarkers such as NF-L, GFAP and Tau-related markers.

  • Low-abundance biomarkers
  • Neurological biomarker analysis
  • Quantitative protein detection
ProteinSimple ELLA
Immunoassay Platforms

ProteinSimple ELLA

Microfluidic sandwich immunoassays enabling independent measurement of up to eight analytes per well, with low sample consumption and no signal interference between channels.

  • Up to 8 analytes per well
  • 5–25 µL sample volume
  • 4-log dynamic range
MSD
Immunoassay Platforms

MSD

Electrochemiluminescence-based immunoassays for sensitive single- and multiplex protein quantification with a broad dynamic range.

  • Multiplex cytokine panels
  • Pharmacokinetic & immunogenicity assays
  • Broad dynamic range
Olink Signature Q100
Immunoassay Platforms

Olink Signature Q100

Proximity Extension Assay technology for highly multiplexed protein biomarker analysis from minimal sample volumes.

  • High-plex protein panels
  • Minimal sample volume
  • Biomarker discovery
ELISA
Immunoassay Platforms

ELISA

Established plate-based immunoassays, available as commercial kits or custom-developed and validated methods.

  • Custom & commercial assays
  • 96- and 384-well formats
  • Method transfer & validation
Roche cobas
Automated Clinical Analysis

Roche cobas

Automated clinical chemistry and immunochemistry analysis for safety parameters and routine testing in clinical studies.

  • Clinical safety parameters
  • Automated high throughput
  • Standardized routine testing
PCR
Molecular Methods

PCR

PCR-based methods for the detection and quantification of nucleic acids in research and study samples.

  • Nucleic acid quantification
  • qPCR-based detection
  • Custom assay adaptation
Find your fit

Different Challenges. Different Technologies.

The most suitable platform depends on the target analyte, required sensitivity, sample volume and study objectives. Explore technologies that may be relevant to your analytical requirements.

What is your analytical challenge?

Relevant Technologies

  • Simoa HD-X

Ultrasensitive digital immunoassays for low-abundance proteins, including neurological biomarkers such as NF-L, GFAP and Tau-related markers.

Technology suggestions are indicative. The final choice depends on the target analyte, sample matrix, assay performance and study requirements.

Our technologies

Technology Spotlights

Detecting Biomarkers at Extremely Low Concentrations.
Simoa HD-X

Detecting Biomarkers at Extremely Low Concentrations.

Simoa HD-X enables the quantitative analysis of low-abundance biomarkers, including neurological markers such as NF-L, GFAP and Tau-related proteins.

Microcoat uses this technology to support biomarker analysis in pharmaceutical research and development, where conventional assay sensitivity may be insufficient.

Discover More
Multiplex Analysis with Minimal Sample Consumption.
ProteinSimple ELLA

Multiplex Analysis with Minimal Sample Consumption.

When sample volume is limited or interference between analytes is a concern, ELLA offers independent measurement in separate microfluidic channels.

Microcoat has worked with the platform since 2014 and uses it for cytokine analysis, low-volume biomarker studies and mid-throughput screening of multiple protein markers.

Discover More
Beyond technology

More Than Advanced Instrumentation.

Selecting the right platform is only one part of a successful analytical project. Microcoat combines analytical technologies with assay transfer, method adaptation, validation and sample analysis.

Bioanalytical & CRO Services
01

Select

Identify a suitable analytical platform based on analyte, matrix and study requirements.

02

Adapt & Validate

Transfer existing methods, adapt assay conditions and validate methods for their intended application.

03

Analyze

Perform non-clinical and clinical sample analysis with a focus on reliable data and defined study milestones.

Knowledge Hub

Understand the Process

View more
Laboratory Services

How does Lateral Flow Testing work?

The capillary-driven technology behind rapid tests, explained step by step.

5 min
Laboratory Services

What is an ELISA?

The plate-based immunoassay that quantifies proteins, antibodies and hormones with a colour change.

5 min
Get in touch

Let's Find the Right Technology for Your Project.

Tell us about your analyte, sample matrix and analytical requirements. Our team will help you identify suitable technologies and assay approaches.

Contact

Tell Us About Your Project

Tell us about your bioanalytical requirements, sample types, and study objectives. Our team will review your inquiry and discuss the next steps.

Technology of Interest

Multiple selections possible

Looking for your diagnostics partner?

From assay development to commercial manufacturing — we support your project at every stage.

Contact us